Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allena Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Allena Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Allena Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is ALNA. The reporting company's CIK number is 1624658.
The total value of stock buying since 2005 is $21,523,992.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-06||Hbm Biocapital Ii Lp||Buy||71,428||14.00||999,992|
|2017-11-06||Frazier Healthcare Vi, L.p. (10% Owner)||Buy||500,000||14.00||7,000,000|
|2017-11-06||Bessemer Venture Partners Vii Institutional L.p. (10% Owner)||Buy||36,000||14.00||504,000|
|2017-11-06||Topper James N (Director)||Buy||500,000||14.00||7,000,000|
|2017-11-06||Starr Kevin P (10% Owner)||Buy||215,000||14.00||3,010,000|
|2017-11-06||Tepper Robert I (Director)||Buy||215,000||14.00||3,010,000|
Insider trading activities including stock purchases, stock sales, and option exercises of ALNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Allena Pharmaceuticals, Inc. (symbol ALNA, CIK number 1624658) see the Securities and Exchange Commission (SEC) website.